Mutares Juggles Record Revenue, a Debt Fix, and an Early Magirus Exit

Mutares posts strong 2025 results with €6.5B revenue and €675M EBITDA, but a bond covenant breach and debt reduction plan overshadow gains, while Magirus exit looms.

Mutares closed 2025 with a headline number that would make most industrial holding companies envious: consolidated revenue of €6.5 billion, up from €5.3 billion the prior year. The group’s holding-level net profit climbed to €130.4 million, while EBITDA ballooned to €675 million from €117 million, largely thanks to the full exit from Steyr Motors. Yet the stock trades around €25, roughly 16 percent lower since January and some 22 percent below its level twelve months ago — a disconnect that has less to do with operating momentum and more with a covenant breach that forced the company into damage control.

The trouble surfaced in the audited annual report. Mutares’s net-debt-to-equity ratio exceeded the threshold stipulated in its bond terms, triggered by valuation effects, a slowdown in value-accretive transactions during the fourth quarter, and a sharp increase in leasing liabilities. The company launched a written consent process for its two Nordic bonds — the 2023/27 and 2024/29 issues — and secured a waiver from bondholders. Management expects the ratio to return to compliance by the end of June 2026, underpinned by the recently signed acquisitions of Wärtsilä Gas Solutions and SABIC’s ETP business.

To get there, Mutares is also leaning on a deliberate debt-reduction plan. Outstanding bonds currently total €385 million, and the target is to pare that back to between €250 million and €300 million. A voluntary tender offer for bondholders is expected to launch around May 8, while from the second quarter of 2026 the company will buy back at least €25 million per quarter of the 2023/27 note.

Magirus: The Exit That Could Change the Narrative

Less than 18 months after acquiring fire-truck specialist Magirus, Mutares is already weighing an exit — either through an IPO or a trade sale. The speed reflects how quickly the Munich-based group has turned around the former problem asset. Magirus’s order backlog now stands well above €800 million, securing full capacity utilisation for 2026 and a large portion of 2027. First-quarter order intake hit a record level, and a growing defence business is opening up what Mutares describes as attractive margin potential.

The timing is no coincidence. Companies with defence exposure are commanding premium valuations, and seasoned financial investors rarely let such a window pass. The Steyr Motors blueprint is instructive: Mutares took over the Austrian high-performance drive manufacturer out of distress in late 2022, restructured it, and sold it at a profit, generating gross proceeds of more than €170 million over the holding period and a return well above the group’s own target range. Magirus is larger, and Mutares’s chief investment officer has called it one of the most promising portfolio holdings.

Adjusted EBITDA Still in the Red

For all the headline growth, Mutares’s adjusted EBITDA — a metric that strips out one-off effects and is more relevant for a private-equity-style holding company — remained negative at minus €31.2 million. That is an improvement from minus €85.4 million a year earlier, but it underscores that the underlying portfolio has not yet swung into positive territory on an adjusted basis.

The board and supervisory board are proposing a dividend of €2.00 per share for the 2025 financial year, to be voted on at the annual general meeting on July 3. That figure is framed as a minimum dividend: if additional exits with material liquidity contributions are completed before the AGM, a supplementary performance dividend could be added.

US Ambitions and a New Chemicals Segment

Beyond the debt and dividend story, Mutares is laying groundwork for two strategic shifts. On the transatlantic front, the company has identified roughly 15 acquisition targets in the United States with a combined revenue pool of €4.8 billion. Closer to home, the SABIC transaction will form the basis of a new “Chemicals & Materials” segment, marking Mutares’s first foray into specialty chemicals and high-performance materials.

For 2026, management has reaffirmed its guidance: consolidated revenue between €7.9 billion and €9.1 billion, and a holding-level net profit of €165 million to €200 million. The longer-term ambition is to grow top-line revenue by at least 25 percent annually through to 2030.

The next milestone comes on May 12, when Mutares publishes its first-quarter report. That will provide an early test of whether the covenant timeline is holding. The AGM on July 3, meanwhile, is likely to see shareholders pressing for more detail on the Magirus exit strategy — a move that, if executed successfully, could do more to revive the stock price than any balance-sheet repair alone.